In our previous preliminary study (Luo et al., 2017), we found that relative 70% decline of PTH was a reasonable indicator of clinical hypocalcemia at 4.67% vs. 27.0% in patients with relative decline of ≤70% and >70%, respectively. The gene discussed is PTH; the disease is Hypocalcemia.